Prosecution Insights
Last updated: April 19, 2026

Sana Biotechnology, Inc.

5 pending office actions • 4 clients

Portfolio Summary

5
Total Pending OAs
0
Final Rejections
5
Non-Final OAs

Client Portfolio (4 clients)

Client (Assignee)Pending OAs
The Children's Hospital of Philadelphia 2
Institut National De La Santé Et De La Recherche Medicale (Inserm) 1
Sana Biotechnology, Inc. 1
Sana Blotechnology, Inc. 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18404389 METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM BLOOD PRODUCTS The Children's Hospital of Philadelphia PYLA, EVELYN Y 1633 Non-Final OA Jan 04, 2024
18179269 METHODS FOR SELECTIVELY MODULATING THE ACTIVITY OF DISTINCT SUBTYPES OF CELLS Institut National De La Santé Et De La Recherche Medicale (Inserm) POPA, ILEANA 1633 Non-Final OA Mar 06, 2023
18023331 MODIFIED ANTI-VIRAL BINDING AGENTS Sana Biotechnology, Inc. BENAVIDES, JENNIFER ANN 1675 Non-Final OA Feb 24, 2023
17639843 CD24-ASSOCIATED PARTICLES AND RELATED METHODS AND USES THEREOF Sana Blotechnology, Inc. VIJAYARAGHAVAN, JAGAMYA NMN 1633 Non-Final OA Mar 02, 2022
17651056 METHODS AND COMPOSITIONS OF CHONDRISOMES The Children's Hospital of Philadelphia PYLA, EVELYN Y 1633 Non-Final OA Feb 14, 2022

Managing Sana Biotechnology, Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month